Best Earnings Power Value Biotechnology Stocks 2026

Top Biotechnology stocks by Earnings Power Value (EPV) upside in 2026. Greenwald-framework valuation updated daily from SEC filings.

160 stocks analyzed Updated 2026-05-29
# Ticker Company QOC Price EPV Upside
1 ATRA Atara Biotherapeutics, Inc. 4.8 $11.26 +496.1%
2 CHRS Coherus Oncology, Inc. 6.8 $1.65 +450.0%
3 MGNX MacroGenics, Inc. 6.2 $4.21 +188.9%
4 ORMP Oramed Pharmaceuticals Inc. 7.1 $3.96 +188.6%
5 MCRB Seres Therapeutics, Inc. 4.1 $7.58 +162.7%
6 PTCT PTC Therapeutics, Inc. 4.1 $71.05 +88.5%
7 ABEO Abeona Therapeutics Inc. 5.5 $5.78 +82.9%
8 MRNA Moderna, Inc. 7.1 $47.57 +80.9%
9 FBIO Fortress Biotech, Inc. 5.9 $2.81 +70.0%
10 RIGL Rigel Pharmaceuticals, Inc. 9.1 $30.05 +69.1%
11 O••• OnKure ••••• •.• $•••.•• ••.•%
12 B••• Black ••••• •.• $•••.•• ••.•%
13 I••• ImageneBio, ••••• •.• $•••.•• ••.•%
14 P••• Protalix ••••• •.• $•••.•• ••.•%
15 T••• Tonix ••••• •.• $•••.•• ••.•%
16 C••• Compugen ••••• •.• $•••.•• ••.•%
17 B••• Biomea ••••• •.• $•••.•• ••.•%
18 I••• Incyte ••••• •.• $•••.•• ••.•%
19 Q••• uniQure ••••• •.• $•••.•• ••.•%
20 A••• ADC ••••• •.• $•••.•• ••.•%
🔒

Unlock the Full Best Earnings Power Value Biotechnology Stocks 2026 List

Screen all 160 Biotechnology stocks with 13 institutional-grade valuation models. Updated daily from SEC EDGAR filings.

Access Full Screening — From $27/mo →

How CirclFi Ranks Biotechnology Stocks

CirclFi analyzes 160 Biotechnology stocks daily using 13 independent institutional-grade valuation models. Each model processes SEC EDGAR 10-K and 10-Q financial filings (700+ XBRL tags), FRED macroeconomic data, and GDELT news sentiment.

The best earnings power value biotechnology stocks 2026 ranking uses epv upside as the primary sort criterion. Models span intrinsic valuation (Bayesian DCF with 10,000 Monte Carlo simulations, EPV), scenario analysis (First Chicago), regime-switching (Markov DDM), and machine learning (ML-RIV, FTNN Topology).